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Introduction
Cryopyrin-Associated Periodic Syndromes (CAPS) are a
group of rare, inherited, autoinflammatory diseases involved
of Familial Cold Autoinflammatory Syndrome (FCAS),
Muckle-Wells Syndrome (MWS) and Neonatal Onset Mul-
tisystem Inflammatory Disease (NOMID) (also called
Chronic Infantile Neurologic Cutaneous Articular, or
CINCA, Syndrome. The responsible gene NLRP3 (nucleo-
tide-binding domain, leucine-rich family [NLR], pyrin
domain containing, produces cryopyrin protein which par-
ticipates in inflammasome complexes leading to production
of interleukin-1b (IL-1b) and autoinflammation.
Objectives
We aimed to investigate possible variations of the genes
linked to CAPS disorders.
Methods
Bidirectional DNA Sequencing analysis was performed
in coding exons and exon-intron flanking regions of
NLRP3 gene (NM_004895.4; NP_004886.3).
Results
Patients with manifestations of hereditary autoinflamma-
tory disorder and MEFV gene mutation negative (n:194)
had undergone mutation analysis of NLRP3 gene.
Disease related mutations were obtained in 25 patients.
p.Gln703Lys in 19 patients, p.Ser726Gly in 2 patients and
p.Val198Met mutation in 1 patient were investigated. In
3 patients, novel pathogenic p.Ala154Gly, p.Ser726Gly
missense, and p.K610fsX613 frameshift mutations were
identified, and registered to ISSAID. Synonimous amino
acid polymorphisms include: p.Thr219Thr (ACC/ACT;
c.657C>T) %14, p.Ala242Ala (GCG/GCA; C.726G>A) %
56.4, p.Arg260Arg (CGA/CGG; c.780A>G) %63.6,
p.Ser434Ser (TCC/TCT; c.1302C>T) %23.4 and p.Leu411-
Leu (c.1231C-T) %0.4. Anti-IL1B treatment was started
for those patients and good response was obtained.
Conclusion
In this study, DNA sequencing analysis revealed novel
NLPR3 mutations which were found related to typical
CAPS phenotype and registered to ISSAID. In particular,
for patients with no identifiable MEFV gene mutation,
genetic diagnosis helps early diagnosis, proper follow-up
and treatment of patients in CAPS disorders. For the
genetic and phenotypic heterogeneity of the patients and
for patients with no identifiable mutations, possible pre-
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